Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 169 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

 		Prostate Cancer Metastatic Phase1, Phase2 United States NCT05067140

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

 		Generalized Myasthenia Gravis Phase1, Phase2 Japan
United States 		NCT06704269

Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study

 		Relapsing Multiple Sclerosis (RMS) Greece NCT06486779

Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

 		Pediatric Chronic Heart Failure Japan NCT06659393

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

 		Familial Hypercholesterolemia - Heterozygous Phase3 Malaysia
United States 		NCT06597019

A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian Federation

 		HR+HER2- Advanced Breast Cancer Russian Federation NCT06625333

An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis

 		Relapsing Multiple Sclerosis Phase1, Phase2 Australia
Switzerland 		NCT06617793

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

 		Relapsing Remitting Multiple Sclerosis (RRMS) Phase4 Canada NCT06733922

A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

 		Metastatic Castration-Resistant Prostate Cancer Phase1 Netherlands
Spain
United Kingdom
United States
View All
 NCT06531499

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

 		Idiopathic Inflammatory Myopathies Phase2 Israel
Japan
United States 		NCT06665256